Relapse: Clinical Trials

1 trial for Relapse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers
Betaine, Peginterferon alpha 2a, Ribavirin - Chronic Hepatitis C, Genotype 1
Early Phase 1TerminatedUniversity of Nebraska22009-05-012023-11-30

Narrower conditions

Hepatitis C, Chronic (1)  ·  Recurrence (1)

Broader conditions

Blood-Borne Infections (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis C (1)  ·  Hepatitis, Chronic (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  RNA Virus Infections (1)

Interventions

Betaine (1)  ·  Ribavirin (1)  ·  peginterferon alfa-2a (1)

Sponsors

University of Nebraska (1)

Countries

United States (1)

Top investigators

Mark E Mailliard, MD (1)